George M. Rehm

Venture Partner at EMBL Ventures GmbH

George M. Rehm

George M. Rehm

Venture Partner at EMBL Ventures GmbH

Overview
Career Highlights

Calibrium Private Investments GmbH
aeris CAPITAL AG

RelSci Relationships

197

Number of Boards

16

Birthday

1949

Age

71

Contact Data
Trying to get in touch with George M. Rehm? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals George M. Rehm likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at EMBL Ventures GmbH

Relationship likelihood: Strong

Founder at Chicago Pacific Founders Fund LP

Relationship likelihood: Strong

President, Chief Scientific Officer & Director at GenomeDx Biosciences, Inc.

Relationship likelihood: Strong

Managing Director at Sector Investment Managers Ltd.

Relationship likelihood: Strong

Chief Scientific Officer at Arrowhead Pharmaceuticals, Inc.

Relationship likelihood: Strong

Head of Corporate Social Responsibility Program in Europe at KPMG LLP

Relationship likelihood: Strong

Managing Partner at Mohr Davidow Ventures

Relationship likelihood: Strong

Former Chairman at Eckoh Plc

Relationship likelihood: Strong

Partner & Chief Executive Officer at Calibrium AG

Relationship likelihood: Strong

Founder at Adamas Pharmaceuticals, Inc.

Relationship likelihood: Strong

In The News
Star Tribune (Minneapolis, Minnesota)
January 3, 2018
READERS WRITE The unspoken selling point
PR Newswire
February 24, 2016
MED-C Expands its Board of Directors
Paths to George M. Rehm
Potential Connections via
Relationship Science
You
George M. Rehm
Venture Partner at EMBL Ventures GmbH
Education
Graduate
Class of 1976

The College of Environmental Design, also known as the Berkeley CED, or simply CED, is one of 14 schools and colleges at the University of California, Berkeley. The school is located in Wurster Hall on the southeast corner of the main UC Berkeley campus. It is composed of three departments: Architecture City and Regional Planning Landscape Architecture and Environmental Planning The CED is consistently ranked as one of the most prestigious design schools in the U.S. and the world. The Graduate Program in Architecture is currently ranked No. 7 in the country by DesignIntelligence.[3] The Urban Planning program is currently ranked No. 2[4] by Planetizen

JD
Class of 1975

The University of California's Hastings College of the Law (UC Hastings or Hastings) is a top tier public law school in San Francisco, California, located in the Civic Center neighborhood. Founded in 1878 by Serranus Clinton Hastings, the first Chief Justice of California, it was the first law school of the University of California and was one of the first law schools established in the Western United States. It is the oldest law school on the West Coast. It is also one of the few university-affiliated law schools in the United States that does not share its campus with undergraduates or other graduate programs.

BSFS in International Affairs
Class of 1970

Georgetown University is a private research university in Washington, D.C. Founded in 1789, it is the oldest Jesuit and Catholic university in the United States. Georgetown's main campus, located in Washington's Georgetown neighborhood, is noted for Healy Hall, a National Historic Landmark in the Romanesque revival style. Georgetown operates a law center on Capitol Hill and auxiliary campuses in Italy, Turkey, and Qatar.

Career History
Venture Partner
Current

EMBL Ventures is a hands-on, long-term manager which invests in disruptive biology and life-science related products and technologies with global potential, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics developed at the EMBL, from EMBL alumni and from non-EMBL third parties.The firm seeks to invest in entrepreneurial management teams with: a combination of relevant technical expertise, drive, business sense and a down-to-earth attitude; ownership of a proprietary core or platform technology generating a proprietary position or clear competitive advantage in a defined market sector and a solution for a problem with a significant advantage in a market of substantial size and the chance to achieve a leading, sustainable market position.EMBL Ventures typically acts as the lead or co-lead investor for initial financing and also participates in follow-up financing. They partner with their investee companies, taking a seat on the board of directors. To maximize the intrinsic value of a technology or product, the firm's investment strategy targets one of the main value inflection points, typically the transition from early development or conceptual stage up to proof of concept.

Managing Partner
2008 - 2012

Calibrium Private Investments is an active manager which invests in innovative small and medium-sized companies in a range of sectors including biotechnology, communications, computer software, food, internet technology and medical. The firm typically participates in start-up, buy-out and expansion/development transactions, mainly in companies in the US, Austria, Germany and Switzerland.

Director
2006 - 2010

TTTech Computertechnik AG engages in the provision of aerospace, space, manufacturing and energy market solutions. The company was founded by Stefan Poledna and Gerog Kopetz in 1998 and is headquartered in Vienna, Austria.

Boards & Committees
Director
Current

Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA.

Non-Executive Director
Prior - 2010

ViaLogy LLC develops technology to improve signal detection against electronic background noise. Its products include SPM, MicroSPM, MPEX Electronic Eye, REPAS, and QRI. The company was founded in 1999 by Sandeep Gulati and is headquartered in Altadena, CA.

Independent Director
2008 - 2014

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

Investments
Details Hidden

PatientWisdom, Inc. develops and operates platform that collects, curates, segments and shares patient stories. The firm offers services to patients and families, healthcare providers, researchers and educators, and manufacturers and payers. The company was founded by Gregory Makoul and Eric Langshur in 2015 and is headquartered in New Haven, CT.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by George M. Rehm. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of George M. Rehm's profile does not indicate a business or promotional relationship of any kind between RelSci and George M. Rehm.